# Barry Greenberg

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/barry-greenberg/

## Facts

| Field | Value |
| --- | --- |
| Citations | 41,104 |
| Field | Heart Failure Treatment and Management |
| h-index | 101 |
| i10-index | 366 |
| Last Known Institution | University of California System |
| OpenAlex ID | https://openalex.org/A5064906147 |
| ORCID iD | https://orcid.org/0000-0002-6605-9385 |
| Works | 716 |

## Researcher papers

- [Characteristics, Treatments, and Outcomes of Patients With Preserved Systolic Function Hospitalized for Heart Failure](https://scholariq.org/papers/characteristics-treatments-and-outcomes-of-patients-with-preserved-systolic/)
- [Systolic Blood Pressure at Admission, Clinical Characteristics, and Outcomes in Patients Hospitalized With Acute Heart Failure](https://scholariq.org/papers/systolic-blood-pressure-at-admission-clinical-characteristics-and-outcomes-in/)
- [Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial](https://scholariq.org/papers/serelaxin-recombinant-human-relaxin-2-for-treatment-of-acute-heart-failure-relax/)
- [A Dose-Dependent Increase in Mortality with Vesnarinone among Patients with Severe Heart Failure](https://scholariq.org/papers/a-dose-dependent-increase-in-mortality-with-vesnarinone-among-patients-with/)
- [Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial](https://scholariq.org/papers/calcium-upregulation-by-percutaneous-administration-of-gene-therapy-in-patients/)
- [The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trial](https://scholariq.org/papers/the-effects-of-the-cardiac-myosin-activator-omecamtiv-mecarbil-on-cardiac/)
- [Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction](https://scholariq.org/papers/fulminant-versus-acute-nonfulminant-myocarditis-in-patients-with-left/)
- [The MOGE(S) Classification for a Phenotype–Genotype Nomenclature of Cardiomyopathy](https://scholariq.org/papers/the-moge-s-classification-for-a-phenotype-genotype-nomenclature-of/)
- [Improving Risk Prediction in Heart Failure Using Machine Learning](https://scholariq.org/papers/improving-risk-prediction-in-heart-failure-using-machine-learning/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Cardiac pacing and defibrillation studies](https://scholariq.org/topics/cardiac-pacing-and-defibrillation-studies/)
- [Mechanical Circulatory Support Devices](https://scholariq.org/topics/mechanical-circulatory-support-devices/)

## Researcher university

- [University of California System](https://scholariq.org/institutions/university-of-california-system/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.